![3-Ethyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine (CAS 3176-52-1) - chemical structure image](https://media.scbt.com/product/3-ethyl1-2-4triazolo3-4-b1-3-4thiadiazol-6-amine-3176-52-1-structure_22_90_b_229052.jpg)
![3-Ethyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine (CAS 3176-52-1) - chemical structure image](https://media.scbt.com/product/3-ethyl1-2-4triazolo3-4-b1-3-4thiadiazol-6-amine-3176-52-1-structure_22_90_t_229052.jpg "Molecular structure of 3-Ethyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine, CAS Number: 3176-52-1")
3-Ethyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine (CAS 3176-52-1)
QUICK LINKS
BML-257 is an potent inhibitor of AKT1 translocation and has been observed to attenuate cannabinoid agonist-simulated neurosphere proliferation. AKT1 is a gene of the AKT family that encode for serine/threonine kinases. AKT1 is associated with pathways of cellular survival and has been implicated as a factor of various cancers. This product is often utilized in experiments concerning phosphoinostitide-3 kinase signaling and the PI3/AKT pathway. BML-257 also inhibits HCV (hepatitis C virus) NS5B RNA-dependent RNA polymerase (RdRp) with an IC50 value of 79 muM. BML-257 is a compound in the field of chemistry, finding extensive applications in various synthetic processes. It plays a significant role in the synthesis of pharmaceuticals, biochemicals, and industrial chemicals.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3-Ethyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine, 500 mg | sc-312980 | 500 mg | $270.00 |